Bayer Partners With Gene-Editing Startup CRISPR To Develop New Drugs
The goal is to create new drugs for hemophilia, heart disease in infants, and Stargardt, a disease that causes blindness.
Gene-editing techniques are on the cusp of transitioning from science fiction to reality.
No comments have been added yet.
David Lidsky's Blog
- David Lidsky's profile
- 3 followers
David Lidsky isn't a Goodreads Author
(yet),
but they
do have a blog,
so here are some recent posts imported from
their feed.
